Skip to main content
Top
Published in: International Journal of Hematology 6/2020

01-12-2020 | Thrombocytopenia | Case Report

A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan

Authors: Ying-Chih Huang, Yu-Hung Shih, Ching-Yeh Lin, Ping-Fang Chiu, Su-Feng Kuo, Jen-Shiou Lin, Ming-Ching Shen

Published in: International Journal of Hematology | Issue 6/2020

Login to get access

Abstract

A 66-year-old woman had experienced abnormal bleeding since the age of 7. Thrombocytopenia was not detected until she was 48, and immune thrombocytopenia was diagnosed at age 66. She also reported experiencing hearing disturbance since the age of 30 and acute renal failure since the age of 61 but reported no visual disturbance. Her younger son, who was 40 years old, also experienced abnormal bleeding since the age of 6, but immune thrombocytopenia was diagnosed as late as age 35. He had no other associated disorders. Laboratory examinations of both mother and son revealed a low platelet count (8000 and 29,000 µL, respectively), giant platelets and Döhle body-like granulocyte inclusion bodies. The mother had a high creatinine level (15.4 mg/dL) and normal liver enzyme levels. MYH9 genetic analysis identified a heterozygous mutation, c.101T>A, p.Val34Glu at exon 2 in both patients. These clinical and laboratory findings were consistent with a diagnosis of an MYH9-related disorder with different phenotypes observed in the same family. MYH9-related disorders were recognised in 2003, but were often misdiagnosed as immune thrombocytopenia, and hence, they have rarely been reported in Taiwan.
Literature
1.
go back to reference Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: May–Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore). 2003;82(3):203–15. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: May–Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore). 2003;82(3):203–15.
2.
go back to reference Sellers JR. Myosins: a divserse superfamily. Biochim Biophys Acta. 2000;1496(1):3–22.CrossRef Sellers JR. Myosins: a divserse superfamily. Biochim Biophys Acta. 2000;1496(1):3–22.CrossRef
3.
go back to reference Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Haemost. 2009;35(2):189–203.CrossRef Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Haemost. 2009;35(2):189–203.CrossRef
4.
go back to reference Toothaker LE, Gonzalez DA, Tung N, Lemons RS, Le Beau MM, Arnaout MA, et al. Cellular myosin heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood. 1991;78(7):1826–33.CrossRef Toothaker LE, Gonzalez DA, Tung N, Lemons RS, Le Beau MM, Arnaout MA, et al. Cellular myosin heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood. 1991;78(7):1826–33.CrossRef
5.
go back to reference Kunishima S, Kojima T, Tanaka T, Kamiya T, Ozawa K, Nakamura Y, et al. Mapping of a gene for May–Hegglin anomaly to chromosome 22q. Hum Genet. 1999;105(5):379–83.CrossRef Kunishima S, Kojima T, Tanaka T, Kamiya T, Ozawa K, Nakamura Y, et al. Mapping of a gene for May–Hegglin anomaly to chromosome 22q. Hum Genet. 1999;105(5):379–83.CrossRef
6.
go back to reference Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, et al. Mutation in MYH9 result in the May–Hegglin, anomaly and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet. 2000;26(1):103–5.CrossRef Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, et al. Mutation in MYH9 result in the May–Hegglin, anomaly and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet. 2000;26(1):103–5.CrossRef
7.
go back to reference Hodge T, Cope MJ. A myosin family tree. J Cell Sci. 2000;113(19):3353–4.PubMed Hodge T, Cope MJ. A myosin family tree. J Cell Sci. 2000;113(19):3353–4.PubMed
8.
go back to reference Althaus K, Greinacher A. MYH-9 related platelet disorders: strategies for management and diagnosis. Transfus Med Hemother. 2010;37(5):260–7.CrossRef Althaus K, Greinacher A. MYH-9 related platelet disorders: strategies for management and diagnosis. Transfus Med Hemother. 2010;37(5):260–7.CrossRef
9.
go back to reference Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol. 2009;10(11):778–90.CrossRef Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol. 2009;10(11):778–90.CrossRef
10.
go back to reference Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May–Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-Like syndromes. Am J Hum Genet. 2001;69(5):1033–45.CrossRef Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May–Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-Like syndromes. Am J Hum Genet. 2001;69(5):1033–45.CrossRef
11.
go back to reference Seri M, Savino M, Bordo D, Cusano R, Rocca B, Meloni I, et al. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet. 2002;110(2):182–6.CrossRef Seri M, Savino M, Bordo D, Cusano R, Rocca B, Meloni I, et al. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet. 2002;110(2):182–6.CrossRef
12.
go back to reference Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux MF, et al. Mutation spectrum and genotype–phenotype correlations in a large French cohort of MYH9-related disorders. Mol Genet Genomic Med. 2014;2(4):297–312.CrossRef Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux MF, et al. Mutation spectrum and genotype–phenotype correlations in a large French cohort of MYH9-related disorders. Mol Genet Genomic Med. 2014;2(4):297–312.CrossRef
13.
go back to reference Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, et al. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat. 2008;29(3):409–17.CrossRef Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, et al. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat. 2008;29(3):409–17.CrossRef
14.
go back to reference Lin JS, Shen MC, Wang CH, Lin CT. Familial macrothrombocytopenia with granulocyte inclusion: a clinical and laboratory problem. J Formos Med Assoc. 1998;97(2):118–22.PubMed Lin JS, Shen MC, Wang CH, Lin CT. Familial macrothrombocytopenia with granulocyte inclusion: a clinical and laboratory problem. J Formos Med Assoc. 1998;97(2):118–22.PubMed
15.
go back to reference Sung CC, Lin SH, Chao TK, Chen YC. R1933X mutation in the MYH9 gene in May–Hegglin anomaly mimicking idiopathic thrombocytopenic purpura. J Formos Med Assoc. 2014;113(1):56–9.CrossRef Sung CC, Lin SH, Chao TK, Chen YC. R1933X mutation in the MYH9 gene in May–Hegglin anomaly mimicking idiopathic thrombocytopenic purpura. J Formos Med Assoc. 2014;113(1):56–9.CrossRef
16.
go back to reference Chang TH, Hwang DY, Chiou PF, Wu CL, Lin CH, Kuo SF, et al. Novel identification of a sporadic MYH9-related disease with Uremia in Taiwanese: a case report and literature review. Acta Nephrolog. 2017;31(1):26–30. Chang TH, Hwang DY, Chiou PF, Wu CL, Lin CH, Kuo SF, et al. Novel identification of a sporadic MYH9-related disease with Uremia in Taiwanese: a case report and literature review. Acta Nephrolog. 2017;31(1):26–30.
17.
go back to reference Toren A, Rozenfeld-Granot G, Rocca B, Epstein CJ, Amariglio N, Laghi F, et al. Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13. Blood. 2000;96(10):3447–511.CrossRef Toren A, Rozenfeld-Granot G, Rocca B, Epstein CJ, Amariglio N, Laghi F, et al. Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13. Blood. 2000;96(10):3447–511.CrossRef
18.
go back to reference Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May–Hegglin anomaly/Sebastian syndrome). Blood. 2001;97(4):1147–9.CrossRef Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May–Hegglin anomaly/Sebastian syndrome). Blood. 2001;97(4):1147–9.CrossRef
19.
go back to reference Pujol-Moix N, Kelly MJ, Hernandez A, Muniz-Diaz E, Espanol I. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9 related disorders. Haematologica. 2004;89(3):330–7.PubMed Pujol-Moix N, Kelly MJ, Hernandez A, Muniz-Diaz E, Espanol I. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9 related disorders. Haematologica. 2004;89(3):330–7.PubMed
20.
go back to reference Pecci A, Canobbio I, Balduini A, Stefanini L, Cisterna B, Marseglia C, et al. Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations. Hum mol Genet. 2005;14(21):3169–78.CrossRef Pecci A, Canobbio I, Balduini A, Stefanini L, Cisterna B, Marseglia C, et al. Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations. Hum mol Genet. 2005;14(21):3169–78.CrossRef
21.
go back to reference Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, et al. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype–phenotype correlations. Hum Mutat. 2014;35(2):236–47.CrossRef Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, et al. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype–phenotype correlations. Hum Mutat. 2014;35(2):236–47.CrossRef
22.
go back to reference Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161–74.CrossRef Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161–74.CrossRef
23.
go back to reference Pham A, Wang J. Bernard-Soulier syndrome: an inherited platelet disorder. Arch Pathol Lab Med. 2007;131(12):1834–6.PubMed Pham A, Wang J. Bernard-Soulier syndrome: an inherited platelet disorder. Arch Pathol Lab Med. 2007;131(12):1834–6.PubMed
24.
go back to reference Köhler M, Hellstern P, Morgenstern E, Mueller-Eckhardt C, Berberich R, Meiser RJ, et al. Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover. Blut. 1985;50(6):331–40.CrossRef Köhler M, Hellstern P, Morgenstern E, Mueller-Eckhardt C, Berberich R, Meiser RJ, et al. Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover. Blut. 1985;50(6):331–40.CrossRef
25.
go back to reference Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of novel GATA1 mutation. Blood. 2001;98(1):85–92.CrossRef Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of novel GATA1 mutation. Blood. 2001;98(1):85–92.CrossRef
26.
go back to reference Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, UKHCDO, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135(5):603–33.CrossRef Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, UKHCDO, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135(5):603–33.CrossRef
Metadata
Title
A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan
Authors
Ying-Chih Huang
Yu-Hung Shih
Ching-Yeh Lin
Ping-Fang Chiu
Su-Feng Kuo
Jen-Shiou Lin
Ming-Ching Shen
Publication date
01-12-2020
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 6/2020
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-02947-1

Other articles of this Issue 6/2020

International Journal of Hematology 6/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine